Search

everythinglearnresearchcommunity

for

Search:↓

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Alopecia areata is hard to treat, but new targeted therapies show promise.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Plucked hair follicles can help diagnose scalp lupus.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Uveodermatological syndrome in dogs is hard to manage and can lead to blindness despite treatment.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Smart microneedles using advanced tech could improve psoriasis treatment.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Leflunomide is more likely to help treat alopecia areata than cause it.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Type-2 immunity may influence skin diseases and could be targeted for treatment.